Evidence map›Paper›PMID 37452020›Full record

ArticleNature communications2023

HypoRiPPAtlas as an Atlas of hypothetical natural products for mass spectrometry database search.

Yi-Yuan Lee, Mustafa Guler, Desnor N Chigumba, Shen Wang, Neel Mittal, Cameron Miller, Benjamin Krummenacher, Haodong Liu, Liu Cao, Aditya Kannan and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Marine natural products.Natural product reports · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Mining raw plant transcriptomic data for new cyclopeptide alkaloids.Beilstein journal of organic chemistry · 2024
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yi-Yuan Lee *Carnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID 0000-0001-5067-7085
Mustafa Guler *Carnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID 0000-0001-5004-8756
Desnor N ChigumbaDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Shen WangCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Neel MittalCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Cameron MillerCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Benjamin KrummenacherCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Haodong LiuCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Liu CaoCarnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID 0000-0002-6326-712X
Aditya KannanCarnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID 0000-0002-3104-7560
Keshav NarayanCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Samuel T SlocumDepartment of Pharmacology, University of North Carolina, Chapel Hill, NC, USA.
Bryan L RothDepartment of Pharmacology, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0002-0561-6520
Alexey GurevichHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, Germany.ORCID 0000-0002-5855-3519
Bahar BehsazCarnegie Mellon University, Pittsburgh, PA, 15213, USA.
Roland D KerstenDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Hosein MohimaniCarnegie Mellon University, Pittsburgh, PA, 15213, USA. hoseinm@andrew.cmu.edu.ORCID 0000-0003-3980-2505

Funding

Integrated Interdisciplinary, inter-university PhD Program Computational Biology (T32)T32EB009403 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BAR-JOSEPH, ZIV · 2009 to 2023
$4.4M
Discovering novel small molecule antibiotics from complex microbial communities by integrating computational mass spectrometry and metagenome miningDP2GM137413 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI MOHIMANI, HOSEIN · 2019 to 2019
$2.2M
Discovery, Biosynthesis and Engineering of Side-Chain-Macrocyclic Plant PeptidesR35GM146934 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Roland David Kersten · 2022 to 2026
$1.8M
NIBIB NIH HHS T32 EB009403NIGMS NIH HHS DP2 GM137413NIGMS NIH HHS R35 GM146934
6 · The paper itself

Abstract

Recent analyses of public microbial genomes have found over a million biosynthetic gene clusters, the natural products of the majority of which remain unknown. Additionally, GNPS harbors billions of mass spectra of natural products without known structures and biosynthetic genes. We bridge the gap between large-scale genome mining and mass spectral datasets for natural product discovery by developing HypoRiPPAtlas, an Atlas of hypothetical natural product structures, which is ready-to-use for in silico database search of tandem mass spectra. HypoRiPPAtlas is constructed by mining genomes using seq2ripp, a machine-learning tool for the prediction of ribosomally synthesized and post-translationally modified peptides (RiPPs). In HypoRiPPAtlas, we identify RiPPs in microbes and plants. HypoRiPPAtlas could be extended to other natural product classes in the future by implementing corresponding biosynthetic logic. This study paves the way for large-scale explorations of biosynthetic pathways and chemical structures of microbial and plant RiPP classes.

Indexed as

Biological ProductsRibosomesDatabases, FactualPeptidesProtein Processing, Post-TranslationalTandem Mass SpectrometryBiological ProductsPeptides

Identifiers

PMID37452020
PMCPMC10349150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.